CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Inovio Pharmaceuticals, Inc. - INO CFD

11.0421
0.5%
Market Trading Hours* (UTC) Opens on Thursday at 13:30

Mon - Fri: 13:30 - 20:00

  • Summary
  • Historical Data
Trading сonditions
Spread 0.0858
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.02629 %
Charges from full value of position ($-5.00)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.02629%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.004068 %
Charges from full value of position ($0.77)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.004068%
Overnight fee time 21:00 (UTC)
Min traded quantity 0.001
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 11.0971
Open 11.0021
1-Year Change 2057.27%
Day's Range 10.6821 - 11.1421
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jul 17, 2024 11.0421 0.1500 1.38% 10.8921 11.1721 10.5721
Jul 16, 2024 11.0971 0.0650 0.59% 11.0321 11.3621 10.8721
Jul 15, 2024 11.0121 -0.3100 -2.74% 11.3221 11.4221 10.8521
Jul 12, 2024 11.2721 0.3600 3.30% 10.9121 11.6621 10.7621
Jul 11, 2024 11.0021 1.6100 17.14% 9.3921 11.1721 9.3821
Jul 10, 2024 9.2421 0.2000 2.21% 9.0421 9.4621 9.0421
Jul 9, 2024 9.1121 0.5900 6.92% 8.5221 9.1371 8.5221
Jul 8, 2024 8.6471 -0.2250 -2.54% 8.8721 9.4221 8.5871
Jul 5, 2024 8.8821 0.6600 8.03% 8.2221 8.9021 8.1321
Jul 3, 2024 8.2821 -0.0900 -1.07% 8.3721 8.4921 8.2171
Jul 2, 2024 8.3921 -0.0900 -1.06% 8.4821 8.8421 8.2721
Jul 1, 2024 8.5521 0.4800 5.95% 8.0721 8.6421 7.7521
Jun 28, 2024 8.0471 0.3950 5.16% 7.6521 8.1821 7.4821
Jun 27, 2024 7.7121 -0.0600 -0.77% 7.7721 8.0721 7.6021
Jun 26, 2024 7.7821 0.2800 3.73% 7.5021 7.9021 7.3121
Jun 25, 2024 7.6621 -0.2300 -2.91% 7.8921 8.0721 7.6521
Jun 24, 2024 7.9371 -0.1850 -2.28% 8.1221 8.2921 7.8621
Jun 21, 2024 8.0521 -0.0200 -0.25% 8.0721 8.2321 7.9821
Jun 20, 2024 8.0421 -0.3800 -4.51% 8.4221 8.4221 8.0221
Jun 18, 2024 8.5321 -0.3800 -4.26% 8.9121 8.9221 8.5021

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Inovio Pharmaceuticals Company profile

Inovio Pharmaceuticals, Inc., a late-stage biotechnology company, focuses on the discovery, development, and commercialization of DNA-based immunotherapies and vaccines to prevent and treat cancers and infectious diseases. Its SynCon immunotherapy design has the ability to break the immune system''s tolerance of cancerous cells, as well as is intended to facilitate cross-strain protection against known, as well as new unmatched strains of pathogens, such as influenza. The company is involved in conducting and planning clinical studies of its proprietary SynCon immunotherapies for human papillomavirus-caused pre-cancers and cancers; glioblastoma multiforme; hepatitis B virus; hepatitis C virus; human immunodeficiency virus; Ebola virus; middle east respiratory syndrome; and Zika virus. Its partners and collaborators include The Wistar Institute; University of Pennsylvania; GeneOne Life Science Inc.; ApolloBio Corporation; Regeneron Pharmaceuticals, Inc.; Genentech, Inc.; Plumbline Life Sciences, Inc.; Drexel University; National Institute of Allergy and Infectious Diseases; United States Military HIV Research Program; U.S. Army Medical Research Institute of Infectious Diseases; National Institutes of Health; HIV Vaccines Trial Network; Defense Advanced Research Projects Agency; the Parker Institute for Cancer Immunotherapy; QIAGEN N.V.; Coalition for Epidemic Preparedness Innovations; and Beijing Advaccine Biotechnology Co. Inovio Pharmaceuticals, Inc. was founded in 1979 and is headquartered in Plymouth Meeting, Pennsylvania.
Industry: Biotechnology & Medical Research (NEC)

6769 Mesa Ridge Rd.
SAN DIEGO
CALIFORNIA 92121
US

People also watch

Gold

2,465.28 Price
+0.230% 1D Chg, %
Long position overnight fee -0.0196%
Short position overnight fee 0.0114%
Overnight fee time 21:00 (UTC)
Spread 0.30

BTC/USD

64,633.20 Price
+0.110% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

US100

19,875.90 Price
+0.290% 1D Chg, %
Long position overnight fee -0.0263%
Short position overnight fee 0.0041%
Overnight fee time 21:00 (UTC)
Spread 1.8

ETH/USD

3,444.04 Price
+0.750% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

Still looking for a broker you can trust?

Join the 630,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading